Optimizing Diagnostic Protocols, Combination Therapies, and Modern MIGS for Early to Advanced Glaucoma

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from Aerie Pharmaceuticals, Alcon Laboratories Inc., Allergan, Inc., Carl Zeiss Meditec, Glaukos, New World Medical, and Santen.
    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
    Activity Expiration DateJuly 31, 2019

    Optimizing Diagnostic Protocols, Combination Therapies, and Modern MIGS for Early to Advanced Glaucoma

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    This activity is supported by educational grants from Aerie Pharmaceuticals, Alcon Laboratories Inc., Allergan, Inc., Carl Zeiss Meditec, Glaukos, New World Medical, and Santen.

    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.

    Activity Expiration DateJuly 31, 2019

    Course Faculty: Ike K. Ahmed, MD, FRCSC, Brian A. Francis, MD, Robert J. Noecker, MD, Constance O. Okeke, MD, and Nathan M. Radcliffe, MD.

    Course Objectives

    Ophthalmologists who attend this course will:

    • Identify the diagnostic protocols necessary to evaluate fluid drainage and optic nerve structure and function to guide glaucoma therapy decisions
    • Analyze the risks and benefits of combination therapy
    • Describe how and when to integrate new MIGS options from early to advanced glaucoma


     

    Product Tags

    Use spaces to separate tags. Use single quotes (') for phrases.